Vimarsana
Biggest News Aggregation in the World

March Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from March Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In March Ventures Today - Breaking & Trending Today

InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup - Vimarsana News

InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup

Plus: Electronic health record company Veradigm’s $140 million AI gamble on startup ScienceIO.

Source: forbes.com
Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board - Vimarsana News

Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board

BOSTON, Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advisory

Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors - Vimarsana News

Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors

Life sciences veteran’s experience leading R&D organizations and bringing more than 25 products to market will support Volastra’s growing pipeline of treatments targeting chromosomally unstable cancersNEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company, today announced the...

Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated KIF18A Inhibitors - Vimarsana News

Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated KIF18A Inhibitors

NEW YORK--(BUSINESS WIRE)--Oct 30, 2023--

bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the w - Vimarsana News

bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the w

CRISPR-Ready ioGlutamatergic Neurons™ are first-in-class stem-cell derived human neurons containing a constitutively-expressed Cas9 nuclease for gene knockouts and CRISPR screens.New cell type creates an opportunity for research and drug discovery scientists to knockout any gene of interest in glutamatergic neurons;...